Tirzep 15 mg/0.5 ml (Tirzepatide INN)

Tirzep 15 mg/0.5 ml (Tirzepatide INN) is an advanced once-weekly injectable therapy designed to support blood glucose control and long-term weight management in adults. It acts on multiple metabolic pathways to improve insulin sensitivity, reduce appetite, and promote healthier glycemic regulation.

Key Therapeutic Benefits:

• Helps improve blood sugar control in adults with Type 2 Diabetes Mellitus.
• Supports significant and sustained weight reduction when combined with diet and exercise.
• Enhances insulin secretion in response to elevated blood glucose levels.
• Reduces excess glucose production by the liver.
• Helps decrease appetite and calorie intake by promoting feelings of fullness.
• Slows gastric emptying, contributing to improved post-meal blood sugar control.
• Supports long-term metabolic health and glycemic stability.
• May help reduce diabetes-related complications through improved glucose management.
• Assists eligible adults with overweight or obesity in achieving weight-management goals.
• Provides convenient once-weekly administration for improved treatment adherence.
• Contributes to better overall metabolic function and healthier body weight maintenance.
• Can be incorporated into a comprehensive diabetes and weight-management program under healthcare supervision.

Active Ingredient:

• Tirzepatide INN – 15 mg/0.5 ml

Composition:
Each pre-filled syringe contains:

• Tirzepatide INN 15 mg
• Sterile aqueous solution for subcutaneous injection
• Pharmaceutical-grade buffering agents
• Stabilizing excipients
• Water for Injection (WFI)

Product Characteristics:

• Clear and colorless to slightly yellow solution
• Intended for subcutaneous administration
• Preservative-free formulation
• Supplied in a ready-to-use pre-filled syringe
• Manufactured according to stringent pharmaceutical quality standards

Recommended Dosage:

• Administer 15 mg once weekly by subcutaneous injection, or as directed by a qualified healthcare professional.
• The maintenance dose should be individualized based on treatment response and tolerability.

Administration Guidelines:

• Inject under the skin of the abdomen, thigh, or upper arm.
• Rotate injection sites with each dose to minimize local skin reactions.
• Administer on the same day each week whenever possible.
• Can be taken with or without food.
• Do not inject into a vein or muscle.
• Inspect the solution before use and do not use if discolored or containing visible particles.

Missed Dose Instructions:

• If a dose is missed, administer it as soon as possible within 4 days (96 hours).
• If more than 4 days have passed, skip the missed dose and continue with the next scheduled weekly dose.
• Do not administer two doses within a short interval to compensate for a missed dose.

Important Safety Information:

• Use only under the supervision of a healthcare provider.
• Follow prescribed dosing schedules carefully.
• Regular monitoring of blood glucose levels may be recommended during treatment.
• Lifestyle modifications, including healthy eating habits and physical activity, should accompany therapy for optimal results.
• Do not alter the dose or discontinue treatment without medical advice.